Cytokine ranking via mutual information algorithm correlates cytokine profiles with presenting disease severity in patients with COVID-19
Preprint
Abstract
Although the range of immune responses to COVID-19 infection is variable, cytokine storm is observed in many affected individuals. To further understand the disease pathogenesis and, consequently, to develop an additional tool for clinicians to evaluate patients for presumptive intervention we sought to compare plasma cytokine levels between a range of donor and patient samples grouped by a COVID-19 Severity Score (CSS) based on need for hospitalization and oxygen requirement. Here we utilize a mutual information algorithm that classifies the information gain for CSS prediction provided by cytokine expression levels and clinical variables. Using this methodology, we found that a small number of clinical and cytokine expression variables are predictive of presenting COVID-19 disease severity, raising questions about the mechanism by which COVID-19 creates severe illness. The variables that were the most predictive of CSS included clinical variables such as age and abnormal chest x-ray as well as cytokines such as macrophage colony-stimulating factor (M-CSF), interferon-inducible protein 10 (IP-10) and Interleukin-1 Receptor Antagonist (IL-1RA). Our results suggest that SARS-CoV-2 infection causes a plethora of changes in cytokine profiles and that particularly in severely ill patients, these changes are consistent with the presence of Macrophage Activation Syndrome and could furthermore be used as a biomarker to predict disease severity.Keywords
All Related Versions
- Published version: eLife, 10.
This publication has 11 references indexed in Scilit:
- MEK inhibitors reduce cellular expression of ACE2, pERK, pRb while stimulating NK-mediated cytotoxicity and attenuating inflammatory cytokines relevant to SARS-CoV-2 infectionOncotarget, 2020
- Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patientsScience Translational Medicine, 2020
- Macrophage activation syndrome and COVID-19Inflammation and Regeneration, 2020
- Cytokine Storm in COVID-19: The Current Evidence and Treatment StrategiesFrontiers in Immunology, 2020
- The COVID-19 Cytokine Storm; What We Know So FarFrontiers in Immunology, 2020
- The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like DiseaseAutoimmunity Reviews, 2020
- Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophagesNature Reviews Immunology, 2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019New England Journal of Medicine, 2020
- Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP)medRxiv, 2020
- CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implicationsCytokine & Growth Factor Reviews, 2011